Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor

Journal of Molecular Recognition

Volumn 17, Issue 4, 2004, Pages 332-338

  Barrios, Yvelise ^a,b   Jirholt, Pernilla ^a,c   Ohlin, Mats ^a  

^a LUND UNIVERSITY   (Sweden)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibody; Antigen; Complementarity determining region; Diversity; Loop; Specificity

Indexed keywords

CA 15-3 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; PEPTIDE LIBRARY;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; GENETICS; HUMAN; IMMUNOLOGY; PROTEIN BINDING;

ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BINDING SITES, ANTIBODY; CA-15-3 ANTIGEN; COMPLEMENTARITY DETERMINING REGIONS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; PEPTIDE LIBRARY; PROTEIN BINDING;

EID: 3142613577     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.679     Document Type: Article

References (29)

1. Al-Lazikani B, Lesk AM, Chothia C. 1997. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273: 927-948.
2. Borrebaeck CAK, Ohlin M. 2002. Antibody evolution beyond nature. Nat. Biotechnol. 20: 1189-1190.
3. Bourgeois C, Bour JB, Aho LS, Pothier P. 1998. Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice. J. Virol. 72: 807-810.
4. Cook GP, Tomlinson IM. 1995. The human immunoglobulin VH repertoire. Immunol. Today 16: 237-242.
5. Edwards BM, Barash SC, Main SH, Choi GH, Minter R, Ullrich S, Williams E, Du Fou L, Wilton J, Albert VR, Ruben SM, Tristan J, Vaughan TJ. 2003. The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BlyS. J. Mol. Biol. 223: 103-118.
6. Epenetos AA, Hird V, Lambert H, Mason P, Coulter C. 2000. Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy. Int. J. Gynecol. Cancer 10: 44-46.
7. Ihle Ø, Beckstrøm KJ, Michaelsen TE. 2003. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis. Scand. J. Immunol. 57: 453-462.
8. Jirholt P, Ohlin M, Borrebaeck CAK, Söderlind E. 1998. Exploiting sequence space: shuffling in vivo rearranged CDR into a master framework. Gene 215: 471-476.
9. Jirholt P, Strandberg L, Jansson B, Krambovitis E, Söderlind E, Borrebaeck CAK, Carlsson R, Danielsson L, Ohlin M. 2001. A central core structure in an antibody variable domain determines antigen specificity. Prot. Eng. 14: 67-73.
10. Jirholt P, Borrebaeck CAK, Ohlin M. 2002. Antibody evolution in vitro from the centre to the periphery-applied to a human antibody fragment recognising the tumour-associated antigen mucin-1. J. Mol. Biol. 318: 407-416.
11. Lamminmäki U. 2003. Towards improved hapten binders: structural characterization and molecular engineering of an anti-17b-estradiol antibody Fab fragment. Ann. Unive. Turk., Ser. Al, thesis Vol. 305.
12. LeFranc M-P. 2003. IMGT, the international ImMunoGeneTics database®. Nucl. Acids Res. 31: 307-310.
13. Levi M, Sällberg M, Rudén U, Herlyn D, Maruyama H, Wigzell H, Marks J, Wahren B. 1993. A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc. Natl Acad. Sci. USA 90: 4374-4378.
14. Martin DA, Bradl H, Collins TJ, Roth E, Jack H-M, Wu GE. 2003. Selection of Ig μ heavy chains by complementarity-determining region 3 length and amino acid composition. J. Immunol. 171: 4663-4671.
15. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552-554.
16. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. 1998. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol. 275: 269-294.
17. Nakouzi A, Casadevall A. 2003. The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan. Mol. Immunol. 40: 351-361.
18. Ohlin M, Borrebaeck CAK. 1996. Characteristics of human antibody repertoires following active immune responses in vivo. Mol. Immunol. 33: 583-592.
19. Ohlin M, Zouali M. 2003. The human antibody repertoire to infectious agents: implications for disease pathogenesis. Mol. Immunol. 40: 1-11.
20. Ohlin M, Owman H, Rioux JD, Newkirk MM, Borrebaeck CAK. 1994. Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B. Mol. Immunol. 31: 983-991.
21. Ørum H, Andersen PS, Øster A, Johansen LK, Riise E, Bjørnvad M, Svendsen I, Engberg J. 1993. Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucl. Acids Res. 21: 4491-4498.
22. Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MFA, Snijdewint FGM, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilkens J, Boer M, Karanikas V, McKenzie IFC, Galanina OE, Simeoni LA, Ter-Grigoryan AG, Belyanchikov IM, Bovin NV, Cao Y, Karsten U, Dai J, Allard WJ, Davis G, Yeung KK, Hanish F-G, Lloyd KO, Kudryashov V, Sikut R, Sikut A, Zhang K, Baeckström D, Hansson GC, Reis CA, Hassan H, Bennett EP, Claussen H, Norum L, Varaas T, Kierulf B, Nustad K, Ciborowski P, Konitzki WM, Magarian-Blader J, Finn OJ, Hilgers J. 1998. Summary report on the ISOBM TD-4 workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol. 19(Suppl. 1): 1-20.
23. Smith GP. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317.
24. Söderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Åberg AM, Nilsson A, Jansson B, Ohlin M, Wingren C, Danielsson L, Carlsson R, Borrebaeck CAK. 2000. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 18: 852-856.
25. Weitkamp J-H, Kallewaard N, Kusuhara K, Bures E, Williams JV, LaFleur B, Greenberg HB, Crowe JE Jr. 2003. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J. Immunol. 171: 4680-4688
26. Wu TT, Johnson G, Kabat EA. 1993. Length distribution of CDRH3 in antibodies. Proteins 16: 1-7.
27. Xu JL, Davis MM. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13: 37-45.
28. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G. 1991. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 173: 395-407.
29. Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW Jr, Kirkham PM. 2003. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol. Biol. 334: 733-749.